The establishment of the Cryogenic Medicine and Cryogenic Bioengineering Branch of Shandong Refrigeration Society and the Academic Exchange Conference were successfully held in Jinan
Release time:
2023-05-21
On May 21, the establishment of the Cryogenic Medicine and Cryogenic Bioengineering Branch of Shandong Refrigeration Society and the Academic Exchange Conference were successfully held in Jinan City, Shandong Province.
The conference invited many domestic authoritative experts in cryogenic biomedicine, such as University of Science and Technology of China, University of Shanghai for Science and Technology, Qilu Hospital of Shandong University, and Reproductive Hospital Affiliated to Shandong University, to make special academic reports for the conference. More than 100 experts from reproductive medicine, orthopedics, hematology, tissue and organ transplantation, cosmetic plastic surgery and rehabilitation, as well as representatives from large enterprises and institutions attended the event to discuss the prospects and future of the development of cryogenic medicine and cryogenic bioengineering.
The meeting was presided over by Han Guangjun, deputy secretary-general of Shandong Refrigeration Society. Li Yongan, executive vice president of Shandong Refrigeration Society, read out the "Notice on the Establishment of the Cryogenic Medicine and Cryogenic Bioengineering Branch of Shandong Refrigeration Society", "Notice on Announcing the List of Persons in Charge of the Cryogenic Medicine and Cryogenic Bioengineering Branch of Shandong Refrigeration Society" and "Decision on the Appointment of Honorary Presidents and Consultants of the Cryogenic Medicine and Cryogenic Bioengineering Branch of Shandong Refrigeration Society". Comrade Shen Baijun and Comrade Bi Yanwen were appointed as honorary presidents, and Comrade Zhang Cheng was appointed as consultants; Comrade Sun Wenyu, deputy director of the Department of Cardiac Surgery of Qilu Hospital of Shandong University, was elected as the first president of the Cryogenic Medicine and Cryogenic Bioengineering Branch; Comrade Yang Jie, Comrade Liu Xinyu, Comrade Tang Rong, Comrade Cui Baoxia, Comrade Zhang Peihai, Comrade Wang Peitao, Comrade Liu Zhicheng, Comrade Liu Jiantao and Comrade Song Minggang were elected as vice presidents; Comrade Zhang Zefeng was elected secretary general.
Subsequently, Li Yongan, executive vice president of Shandong Refrigeration Society, issued a letter of appointment to Sun Wenyu, the newly elected president of the Cryogenic Medicine and Cryogenic Bioengineering Branch; Zhu Chuantang, chairman of the board of supervisors of Shandong Refrigeration Society, issued a letter of appointment to the vice president of the branch. The newly elected President Sun Wenyu issued a letter of appointment to the secretary general of the branch.
山东大学齐鲁医院林亚杰副书记、银丰生物集团总裁张诚、低温医学与低温生物工程分会会长孙文宇分别进行会议致辞。
低温医学与低温生物工程分会会长孙文宇表示，“十四五”时期是推进医工协同高质量发展的关键时期。低温医学与低温生物工程分会的成立，整合了来自生殖医学科、骨科、心外科、妇科、干细胞、整形美容、器官移植等方向优势医疗资源及优势企业资源，将有效促进低温医学技术、低温生物工程技术、设备及成果转化。未来将会充分利用平台优势，推动高水平医工交叉，促进低温医学领域科技自立自强。
At the meeting, Professor Zhao Gang of the University of Science and Technology of China, Professor Liu Baolin of the University of Shanghai for Science and Technology, and Director Tang Rong of the Affiliated Reproductive Hospital of Shandong University made special academic reports; Yinfeng Cryogenic Medical Technology Co., Ltd. also made a wonderful report on "research on deep cryopreservation of tissues and organs" around cryomedicine.
The successful convening of the Cryogenic Medicine and Cryogenic Bioengineering Branch of Shandong Refrigeration Society and the Academic Exchange Conference will play a positive role in promoting the prosperity and development of medical science and technology, promoting the construction of a healthy China, and building a bridge between medical units and enterprises.
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
